South Korea-based Lotte Biologics has signed a manufacturing agreement with an Asia-based biotech company for ...
BioDuro is expanding its global contract research, development and manufacturing organisation (CRDMO) network with the o...
AGC Biologics has announced a strategic decision about the large-scale single-use technology it will use at it...
The pharmaceutical sector, which is one of the highest emitters of carbon, is no exception. According to Deloitte, more ...
Xcell Biosciences Australia Pty Ltd, an Australian affiliate of the San Francisco-based instrumentation company focused ...
ENCell Co., Ltd., a South Korean biotech company specialising in advanced biopharmaceutical contract development and man...
Amaran Biotechnology Inc., a subsidiary of OBI Pharma specialising in Contract Development and Manufacturing Organizatio...
WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialisi...
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced a significant exp...
Syngene International Limited, a global contract research, development, and manufacturing organization (CRDMO), has anno...
Boehringer Ingelheim’s biopharmaceutical facility in Shanghai, China, meets the conditions to participate in a reg...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
WuXi Biologics, a leading global contract research, development, and manufacturing organization (CRDMO...
CDMO Live has emerged as the definitive industry gathering, bringing together Europe's leading pharmaceutical outsourcin...
China-based WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization...
Jubilant Biosys Innovative Research Services Pte Limited, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys Limited, ...
Chime Biologics has a vision to make biologics more accessible and affordable. How does this vision drive your day-to-da...
At the 2025 J.P. Morgan Healthcare Conference held recently, now in its 43rd year, South Korea-based Lotte Biologics unv...
